Milestone Pharmaceuticals, Inc. (MIST)
0.7926
-0.07
(-8.05%)
USD |
NASDAQ |
Sep 24, 16:00
0.7926
0.00 (0.00%)
After-Hours: 19:59
Milestone Pharmaceuticals Total Return Level : 0.862 for Sept. 23, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 23, 2026 | 0.862 |
| September 22, 2026 | 0.921 |
| September 21, 2026 | 0.9178 |
| September 18, 2026 | 0.9158 |
| September 17, 2026 | 0.9196 |
| September 16, 2026 | 0.8892 |
| September 15, 2026 | 0.9277 |
| September 14, 2026 | 0.9494 |
| September 11, 2026 | 0.9801 |
| September 10, 2026 | 1.05 |
| September 09, 2026 | 1.07 |
| September 08, 2026 | 1.125 |
| September 04, 2026 | 1.20 |
| September 03, 2026 | 1.21 |
| September 02, 2026 | 1.18 |
| September 01, 2026 | 1.14 |
| August 31, 2026 | 1.16 |
| August 28, 2026 | 1.16 |
| August 27, 2026 | 1.19 |
| August 26, 2026 | 1.18 |
| August 25, 2026 | 1.16 |
| August 24, 2026 | 1.04 |
| August 21, 2026 | 1.055 |
| August 20, 2026 | 1.03 |
| August 19, 2026 | 1.08 |
| Date | Value |
|---|---|
| August 18, 2026 | 1.07 |
| August 17, 2026 | 1.10 |
| August 14, 2026 | 1.10 |
| August 13, 2026 | 1.07 |
| August 12, 2026 | 1.125 |
| August 11, 2026 | 1.27 |
| August 10, 2026 | 1.26 |
| August 07, 2026 | 1.22 |
| August 06, 2026 | 1.18 |
| August 05, 2026 | 1.145 |
| August 04, 2026 | 1.17 |
| August 03, 2026 | 1.12 |
| July 31, 2026 | 1.11 |
| July 30, 2026 | 1.15 |
| July 29, 2026 | 1.04 |
| July 28, 2026 | 1.07 |
| July 27, 2026 | 1.13 |
| July 24, 2026 | 1.16 |
| July 23, 2026 | 1.20 |
| July 22, 2026 | 1.19 |
| July 21, 2026 | 1.23 |
| July 20, 2026 | 1.18 |
| July 17, 2026 | 1.185 |
| July 16, 2026 | 1.24 |
| July 15, 2026 | 1.27 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| InMed Pharmaceuticals, Inc. | 1.38 |
| NervGen Pharma Corp. | 1.96 |
| Clearmind Medicine, Inc. | 0.85 |
| Lexaria Bioscience Corp. | 3.235 |
| Target Group, Inc. (Canada) | 0.0008 |